Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.
Brunswick Is Sailing Against Headwinds, Analyst Sees Weak Outlook
Raymond James analyst Joseph Altobello downgraded Brunswick Corp (NYSE: BC) to Market Perform from Outperform and removed the prior